| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.2559 | 49 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.2203 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.71 | 48 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.656 | 30 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.6901 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.7204 | 56 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.0372 | 41 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.0691 | 41 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.3128 | 14 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.4532 | 43 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.322 | 38 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.6872 | 26 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.8908 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.6625 | 40 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.4658 | 24 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.3953 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.0186 | 54 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.5186 | 53 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.7544 | 44 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.1552 | 18 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.3201 | 24 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.7443 | 21 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.1119 | 28 |